International Society of Hypertension

December 2015 issue - ISH Hypertension News

The December 2015 issue of ISH Hypertension News is now available. This includes coverage of the results of four trials, all of which have important implications for clinical practice in relation to improving CVD prevention. Three of these trials - SPRINT and two PATHWAYS trials - have clinical implications for hypertension management (how low to go and how to do it) and one EMPA-REG provides unique data regarding optimal glucose lowering with a new class of agents for the prevention of CVD in patients with type 2 diabetes!

December issue ISH Hypertension News

Click here for the December newsletter web version

Click here to view the December newsletter  - PDF version


Contents -  December 2015 issue

Report from Editor Lars H. Lindholm
From The ISH President Rhian Touyz


Hot Off The Press

(1) PATHWAYS to Optimal Treatment of Hypertension: A commentary on the British Hypertension Society PATHWAY Programme of Trials

(2) Can we translate the results of SPRINT into clinical practice? 

(3) Empagliflozin: a paradigm shift or just another diuretic?

(4) Sex-Specific Effect of Endothelin in the Blood Pressure Response to Acute Angiotensin II in Growth-Restricted Rats



(1) Peter Sever

(2) Lars H. Lindholm, Thomas Kahan and Neil Poulter

(3) Thomas Kahan

(4) Muhammad Oneeb Rehman Mian

Institute Focus - Danderyd University Hospital Hypertension Centre, Stockholm, Sweden

 Thomas Kahan

Sex or gender? - Conceptual confusion is common

 Katarina Hamberg and

 Susan P. Phillips

PCSK9 inhibitors

 Peter Sever and

 Judy Mackay

Spotlight on the ISH New Investigator Programme, AHA Hypertension Council Scientific Sessions, September 2015

 Dylan Burger,

 Fady Hannah-Shmouni,

 Cesar Romero and

 Lucinda Hilliard

Where to publish - the role of the impact factor

 Lars H. Lindholm

Christmas Menu


Council's Corner - Hypertension Issues; A Personal View

 Hermann Haller

 Cheol-Ho Kim

Seminar on Hypertension  Lars H. Lindholm

World Heart Federation Hypertension Roadmap

 Alma Adler

 Dike Ojji

 Anastase Dzudie

 Mark Nelson

World Hypertension League report

 Dan Lackland

Membership and Corporate Member Information




Past issues of ISH Hypertension News

September 2015 issue / Opus 42

Click here to view the September newsletter  - PDF version

Click here for the September newsletter web version


Contents -  September 2015 issue

Report from Editor Lars H. Lindholm
From The ISH President Rhian Touyz


Hot Off The Press

  1. Beneficial effects of baroreceptor activation treatment in chronic heart failure
  2. Discontinuation of Antihypertensive Treatment in Elderly People on Cognitive Functioning Trail (Dante)
  3. Take the Pill!
  4. New voices to be heard on high blood pressure
  5. Impact of grief on blood pressure
  6. Increased phosphorylation of the renal Na+Cl - cotransporter in male kidney transplant recipient patients with hypertension: a prospective cohort



  1. Thomas Kahan
  2. Bo Carlberg
  3. Bo Carlberg
  4. Lars H. Lindholm
  5. Lars H. Lindholm
  6. Dylan Burger


ISH 2016 Biennial Scientific Meeting, Seoul, Korea


Institute Focus - Clinica Medica, Brescia, Italy

 Enrico Agabiti Rosei

 New President Elect: Neil Poulter

 Lars H. Lindholm

 Hypertension in Pregnancy

 David Churchill and

 Gareth Beevers

 Statins and Myalgia: Fact or Fiction?

 Peter Sever

 Pulmonary hypertension 2015

 Martin R. Wilkins

 Biochemical testing for non-adherence to antihypertensive medications

 Pankaj Gupta,

 Prashanth  Patel,

 Adrian Stanley,

 Bryan Williams and

 Maciej Tomaszweski

 Reports (x 2) of the First ISH - APSH Summer School in Asia and Australasia

  1.  Trefor Morgan
  2.  Sofie Brouwers and  Fadi Charchar

 ESH 2015 - Meeting Reports

  1. Introduction
  2. Meeting report from the organisers  / ESH representatives
  3. Recent findings in Epidemiology
  4. Can the polypill tacklet the huge challenge of adherence?
  1.  Lars H. Lindholm
  2. Giuseppe Mancia and Anna Dominiczak
  3. Ruan Kruger
  4. Sofie Brouwers

World Health Summit - Advert


 ISH Biennial Meetings - Looking back and looking forward

 Lars H. Lindholm

WHL report

 Mark Niebylski

Council's Corner - Hypertension Issues; A Personal View

  • Markus Schlaich: Device-based approaches for hypertension treatment - do we really need them?
 Markus Schlaich

Membership Information

ISH Corporate Members  


June 2015 / Opus 41

Click here to view the June newsletter  - PDF version

Click here for the June newsletter web version


Contents - June 2015 issue

Report from Editor Lars H. Lindholm
From The ISH President Rhian Touyz

New Investigator Committee Update

Networking and Mentorship Event

Fadi Charchar


Institute Focus - Centre for Chronic Disease Control, New Delhi, India

 Dorairaj Prabhakaran

Hot Off The Press

  • Aortic/brachial pulse wave velocity ratio a better marker of vascular and prognosis stiffness?
  • A place for arterio-venous anastomosis in resistant hypertension 
  • Benefit against risk with thrombolysis in acute ischemic stroke
  • Vascular Type 1A Angiotensin II Receptors Control BP by Regulating Renal Blood Flow and Urinary Sodium Excretion


Thomas Kahan

Thomas Kahan

Bo Carlberg & Mattias Brunström

Dylan Burger and Oneeb Mian

 TIME: Is dosing time important for treating hypertension?

Amy Rogers

 Council's Corner - Hypertension Issues; A Personal View

  • Sympathetic Activation in Hypertension: pathophysiological role and target for treatment

 Guido Grassi 

 World Hypertension League:

  • Report on the Celebration of World Hypertension Day 2015
  • An Update on Hypertension Prevention & Control in Sub-Subharan Africa 2015

Mark Niebylski

Air Pollution and Vascular Health

Jenny A. Bosson and

Jeremy P. Langrish

Membership Information


ISH Corporate Members   


ISH 2016 Seoul Meeting




March 2015 / Opus 40

Click here to view the March newsletter

Click here for the PDF version


Contents - March 2015 issue

Report from Editor Lars H. Lindholm
From The ISH President Rhian Touyz

Hot Off The Press

  • Renal Denervation - again a topic for discussion
  • Left ventricular geometry in hypertension & prognosis
  • AT2R Agonist, Compound 21, Is Reno-Protective Against Type 1 Diabetic Nephropathy


Lars H. Lindholm

Thomas Kahan

Dylan Burger

World Hypertension Day - 17 May


Institute Focus

Stéphane Laurent

Alta Schutte - Award Winner

Lars H. Lindholm

New Investigator Committee Update:

Media New Investigator Committee Working Group update


Dylan Burger

Improve It - combination therapy comes of age

 Colin Baigent

Council's Corner - Hypertension Issues; A Personal View

  • Cognitive Protection in Hypertension: Ready for Prime Time
  • Salt-sensitive hypertension - what does the future hold?


Naftali Stern

Richard Wainford

Gender aspects in hypertension treatment 

with a commentary by Neil Poulter

Charlotta Ljungman and

Karin Manhem

In Memoriam: John Laragh


Membership Information


ISH Corporate Members   


ISH 2016 Seoul Meeting




December 2014 / Opus 39 

PDF version - December newsletter

Flipbook version - December newsletter

Contents December issue

Report from Editor Lars H. Lindholm
From The ISH President Rhian Touyz

Hot Off The Press

Baroreceptor activation therapy

DC isoketal-modified proteins activate T cells and promote hypertension


Peter W. De Leeuw

Dylan Burger

Institute Focus

George Bakris

New Investigator Committee Update:

Spotlight Feature


Fady Hannah-Shmouni

From the ISH 2015 Austin Doyle Award Winner:

Dietary nitrate to reduce blood pressure lowering in hypertensive patients: a randomised, double blind, placebo controlled clinical trial.


Vika Kapil

Council's Corner - Hypertension Issues; A Personal View

Masatsugu Horiuchi,

Yoshihiro Kokubo and

Dorairaj Prabhakaran

World Hypertension League Update:
A comment on recent highlighted salt papers

Dan Lackland


In Memoriam: Peter van Zwieten

John Chalmers and
Giuseppe Mancia

Membership Information


ISH 2016 Seoul Meeting


ISH Corporate Members




September 2014 / Opus 38

 Simple PDF version - September newsletter

Flipbook version - September newsletter                    


Contents September issue

Report from Editor Lars H. Lindholm
From The ISH President Rhian Touyz

Hot Off The Press

The TASMIN-SR Trial. The new way to treat hypertension

A selective microRNA-based strategy inhibits restenosis while preventing endothelial function


Bo Carlberg

Dylan Burger

Council's Corner - Hypertension Issues; A Personal View

Basden Onwubere and
Maciej Tomaszewski

New Investigator Committee Update:
Report on the Athens and San Francisco 2014 meeting programme

Dylan Burger and
Fady Hannah-Shmouni

Hypertension Athens Meeting:

  • Award and Prize Winners
  • 2014 Franz Volhard Lectureship
  • ISH/WHL Dietry Salt Session
  • Putting the A back into RAAS
  • Glasgow - 202 Meeting


Toshiro Fujita
Dan Lackland
Louise Burrell and
Anastasia Susie Mihailidou

World Hypertension League Update:

Norm Campbell

Membership Information


ISH 2016 Seoul Meeting

ISH Corporate Members  



June 2014 / Opus 37

Simple PDF version - June newsletter

Flipbook version - June newsletter

 April 2014 / Opus 36

Simple PDF version - April newsletter

Flipbook version - April newsletter

January 2014 / Opus 35


September 2013 / Opus 34

 April 2013 / Opus 33


November 2012 / Opera 31 - 32

 June 2012 / Opus 30

 March 2012 / Opus 29


 December 2011 / Opus 28

October 2011 / Opus 27

June 2011 / Opus 26

March 2011 / Opus 25


December 2010 / Opus 24

June 2010  / Opus 23

March 2010 / Opus 22


 December 2009  / Opus 21

September 2009 / Opus 20

June 2009 / Opus 19

March 2009 / Opus 18


September 2008 / Opus 17

April 2008 / Opus 16

January 2008 / Opus 15


October 2007 / Opus 14

 July 2007 / Opus 13

March 2007 / Opus 12


December 2006 / Opus 11

September 2006 / Opus 10

March 2006 / Opus 9


 October 2005 / Opus 8

May 2005 / Opus 7

February 2005 / Opus 6


October 2004 / Opus 5

May 2004 / Opus 4

January 2004 / Opus 3


November 2003 / Opus 2

September 2003 / Opus 1



Join ISH in 3 simple steps...Apply Now

Latest tweets from ISH

The ISH is positively committed to opposing discrimination against people on the grounds of gender, race, colour, nationality, religion, marital status, sexual orientation, class, age, disability, having dependants, HIV status or perceived lifestyle.